Trasis

Trasis was created in 2004 by professionals experienced in the development of innovative solutions for the radiopharmaceutical industry.

[Trasis @trasis_pet]

SNMMI in Vancouver: http://t.co/2ifzZ9xwiN

[Trasis @trasis_pet]

BioWin, pôle wallon à success stories http://t.co/iTEJGs82 @lalibrebe

[Trasis @trasis_pet]

TRASIS (Ans, Belgium) gets global recognition with development of the first GMP (Good Manufacturing Practice) universa…http://t.co/avwkzmXA

[Health Imaging @HealthImaging]

PiB & florbetapir provide consistent results for Alzheimer’s eval http://t.co/WrwDOrLP

[Tom @usmolecular]

PET/CT has advantages for advanced breast cancer cases - http://t.co/Pt1i7umu http://t.co/E5KmEtSK

[Tom @usmolecular]

Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity. http://t.co/06bsydOh

[Trasis @trasis_pet]

Good news for imaging as well. http://t.co/7qdPSfVg

[Trasis @trasis_pet]

EANM 2012 at Milan

[Trasis @trasis_pet]

Trasis at EANM 2012 in Milan #radiochemistry #Radiopharmacy #pet

[Tom @usmolecular]

Characterization of Neuroblastic Tumors Using 18F-FDOPA PET. http://t.co/y5CtVjMf

[Tom @usmolecular]

18F-FDG PET/CT in Staging Patients with Locally Advanced or Inflammatory Breast Cancer: Comparison to Conventional... http://t.co/qWwoEfKP

[Trasis @trasis_pet]

Nucleophilic FDOPA is now available on AllinOne by Trasis @trasis_pet #radiochemistry #Radiopharmacy #pet #fdopa

[Trasis @trasis_pet]

In training with @alpi_arebs and @amaranthe # cristallhub